Top Markets
Coin of the day
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited

SUNPHARMA
Rang in aandelen #477
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company,... Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Aandeelprijs
$19.63
Marktkapitalisatie
$47.10B
Verandering (1 dag)
1.80%
Verandering (1 jaar)
-7.33%
Land
IN
Handel Sun Pharmaceutical Industries Limited (SUNPHARMA)

Categorie

Winst voor Sun Pharmaceutical Industries Limited (SUNPHARMA)
Winst in Dec 2025 TTM: $1.64B
Volgens de meest recente financiële verslagen van Sun Pharmaceutical Industries Limited bedraagt de huidige winst van het bedrijf $1.64B. In 2024 behaalde het bedrijf een winst van $1.33B, een stijging ten opzichte van de winst van 2023, die $1.14B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Sun Pharmaceutical Industries Limited van 2004 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $1.64B 2.22%
2025 $1.61B 21.21%
2024 $1.33B 16.34%
2023 $1.14B 93.65%
2022 $588.17M 54.49%
2021 $380.72M -42.58%
2020 $663.01M 20.88%
2019 $548.49M 3.41%
2018 $530.42M -62.03%
2017 $1.40B 40.80%
2016 $992.01M -3.13%
2015 $1.02B 33.99%
2014 $764.30M -3.90%
2013 $795.33M 20.15%
2012 $661.93M 44.90%
2011 $456.82M 45.01%
2010 $315.02M -17.95%
2009 $383.94M -3.94%
2008 $399.69M 107.87%
2007 $192.27M 43.47%
2006 $134.02M 39.03%
2005 $96.39M 9.76%
2004 $87.82M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$651.61M -60.31%
FR
$3.88B 136.40%
DE
$1.32B -19.32%
JP
$3.36B 104.66%
US
$4.84B 194.62%
GB